Category: Q&A

Monitoring Clinically Actionable Proteins- A Q&A with Gordon Mills, MD Anderson Cancer Center

NanoString sat down with Gordon Mills, M.D., Ph.D., Chair of Systems Biology Department at MD Anderson Cancer Center in Houston and lead developer of The Cancer Proteome Atlas (TCPA), to talk about the value of cataloging proteins and the future...

/ March 20, 2017